Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

References

• Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413–1420.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Facchetti F, Re A, et al Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma 2005;46:77–81.
   PubMed Web of Science ®Google Scholar
• Colomo L, Loong F, Rives S, et al Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736–747.
   PubMed Web of Science ®Google Scholar
• Demasi AP, Magalhaes MH, Furuse C, et al Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Dis 2008;14:741–746.
   PubMed Web of Science ®Google Scholar
• Dong HY, Scadden DT, de Leval L, et al Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005;29:1633–1641.
   PubMed Web of Science ®Google Scholar
• Ferrazzo KL, Mesquita RA, Aburad AT, et al EBV detection in HIV-related oral plasmablastic lymphoma. Oral Dis 2007;13:564–569.
   PubMed Web of Science ®Google Scholar
• Folk GS, Abbondanzo SL, Childers EL, et al Plasmablastic lymphoma: a clinicopathologic correlation. Ann Diagn Pathol 2006;10:8–12.
   PubMedGoogle Scholar
• Gaidano G, Cerri M, Capello D, et al Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol 2002;119:622–628.
   PubMed Web of Science ®Google Scholar
• Goedhals J, Beukes CA, Cooper S. The ultrastructural features of plasmablastic lymphoma. Ultrastruct Pathol 2006;30:427–433.
   PubMed Web of Science ®Google Scholar
• Teruya-Feldstein J, Chiao E, Filippa DA, et al CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004;15:1673–1679.
   PubMed Web of Science ®Google Scholar
• Vega F, Chang CC, Medeiros LJ, et al Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005;18:806–815.
   PubMed Web of Science ®Google Scholar
• Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 2007;51:774–777.
   PubMed Web of Science ®Google Scholar
• Simonitsch-Klupp I, Hauser I, Ott G, et al Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 2004;18:146–155.
   PubMed Web of Science ®Google Scholar
• Kim JE, Kim YA, Kim WY, et al Human immunodeficiency virus-negative plasmablastic lymphoma in Korea. Leuk Lymphoma 2009;50:582–587.
   PubMed Web of Science ®Google Scholar
• Ustun C, Reid-Nicholson M, Nayak-Kapoor A, et al Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol 2009;88:351–358.
   PubMed Web of Science ®Google Scholar
• Robak T, Urbanska-Rys H, Strzelecka B, et al Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol 2001;67:322–327.
   PubMed Web of Science ®Google Scholar
• Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008;83:804–809.
   PubMed Web of Science ®Google Scholar
• Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis 2009;15:38–45.
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, ad Gaidano G. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004;28:1538–1540; author reply 1540.
   PubMed Web of Science ®Google Scholar
• Cioc AM, Allen C, Kalmar JR, et al Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004;28:41–46.
   PubMed Web of Science ®Google Scholar
• Zaragoza V, Martinez L, Perez-Ferriols A, et al [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV infection]. Actas Dermosifiliogr 2008;99:820–821.
   PubMedGoogle Scholar
• Dales JP, Harket A, Bagneres D, et al [Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin]. Ann Pathol 2005;25:45–49.
   PubMed Web of Science ®Google Scholar
• Foltyn W, Kos-Kudla B, Sieminska L, et al [Unique case of caecum plasmablastic lymphoma CD138(+) in patient with late diagnosed colon neuroendocrine carcinoma]. Endokrynol Pol 2006;57:160–165.
   PubMedGoogle Scholar
• Stein H, Harris N, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of the haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp. 256–257.
   Google Scholar
• Miller CS, Berger JR, Mootoor Y, et al High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006;44:2409–2415.
   PubMed Web of Science ®Google Scholar
• Walling DM, Flaitz CM, Nichols CM. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 2003;188:883–890.
   PubMed Web of Science ®Google Scholar
• Sirera G, Videla S, Pinol M, et al High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. Aids 2006;20:1201–1204.
   PubMed Web of Science ®Google Scholar
• Bohlius J, Schmidlin K, Costagliola D, et al Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. Aids 2009;23:2029–2037.
   PubMed Web of Science ®Google Scholar
• Lim ST, Karim R, Tulpule A, et al Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 2005;23:8477–8482.
   PubMed Web of Science ®Google Scholar
• Johnson NA, Boyle M, Bashashati A, et al Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 2009;113:3773–3780.
   PubMed Web of Science ®Google Scholar
• Isobe Y, Sugimoto K, Takeuchi K, et al Neural cell adhesion molecule (CD56)-positive B-cell lymphoma. Eur J Haematol 2007;79:166–169.
   PubMed Web of Science ®Google Scholar
• Weisberger J, Gorczyca W, Kinney MC. CD56-positive large B-cell lymphoma. Appl Immunohistochem Mol Morphol 2006;14:369–374.
   PubMedGoogle Scholar
• Knecht H, Berger C, Rothenberger S, et al The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001;60:289–302.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Winer ES, Stachurski D, et al Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma. Oncologist 2010;15:293–299.
   PubMed Web of Science ®Google Scholar
• Kane S, Khurana A, Parulkar G, et al Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing country. J Oral Pathol Med 2009;38:138–144.
   PubMed Web of Science ®Google Scholar